Propylparaben
CAS 94-13-3
Propylparaben (CAS 94-13-3) is a pharmaceutical compound with 3 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 28855.942424242425 nM | 33 | - |
| - | Potency | 30334.848275862067 nM | 22 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| PROPYLPARABEN | 34706 | SU | MTHSPL |
| Propylparaben | 34706 | SU | MTHSPL |
| propylparaben | 34706 | SU | MTHSPL |
| propylparaben | 34706 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Propylparaben used for in pharmaceutical contexts?
Propylparaben (CAS 94-13-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Propylparaben?
No adverse-event association or SIDER side-effect rows are rendered for Propylparaben in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Propylparaben also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Propylparaben with EU status "restricted".
What clinical phase is Propylparaben in?
No phase 1-4 clinical development badge is rendered for Propylparaben because the matched compound identifier rows do not contain a max-phase value.